These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Discovery and Structure-Resistance Relationship Study of New Thieno[2,3- Xiao KJ; Zuo WQ; Xu Y; Tao X; Yu LT; Wang NY Pharmazie; 2019 Jun; 74(6):321-325. PubMed ID: 31138367 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-HCV activity evaluation of anilinoquinoline derivatives. Peng HK; Lin CK; Yang SY; Tseng CK; Tzeng CC; Lee JC; Yang SC Bioorg Med Chem Lett; 2012 Jan; 22(2):1107-10. PubMed ID: 22204909 [TBL] [Abstract][Full Text] [Related]
6. Computer-aided identification, synthesis and evaluation of substituted thienopyrimidines as novel inhibitors of HCV replication. Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Brancale A Eur J Med Chem; 2016 Nov; 123():31-47. PubMed ID: 27474921 [TBL] [Abstract][Full Text] [Related]
7. 3-Biphenylimidazo[1,2-a]pyridines or [1,2-b]pyridazines and analogues, novel Flaviviridae inhibitors. Enguehard-Gueiffier C; Musiu S; Henry N; Véron JB; Mavel S; Neyts J; Leyssen P; Paeshuyse J; Gueiffier A Eur J Med Chem; 2013 Jun; 64():448-63. PubMed ID: 23665801 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and hepatitis C antiviral activity of 1-aminobenzyl-1H-indazole-3-carboxamide analogues. Shi JJ; Ji FH; He PL; Yang YX; Tang W; Zuo JP; Li YC ChemMedChem; 2013 May; 8(5):722-5. PubMed ID: 23512654 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and structure-activity relationships of novel imidazo[4,5-c]pyridine derivatives as potent non-nucleoside inhibitors of hepatitis C virus NS5B. Liu M; Xu Q; Guo S; Zuo R; Hong Y; Luo Y; Li Y; Gong P; Liu Y Bioorg Med Chem; 2018 May; 26(9):2621-2631. PubMed ID: 29681484 [TBL] [Abstract][Full Text] [Related]
10. Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: further optimization of anti-hepatitis C virus activity. Puerstinger G; Paeshuyse J; Heinrich S; Mohr J; Schraffl N; De Clercq E; Neyts J Bioorg Med Chem Lett; 2007 Sep; 17(18):5111-4. PubMed ID: 17656093 [TBL] [Abstract][Full Text] [Related]
11. Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication. Najda-Bernatowicz A; Krawczyk M; Stankiewicz-Drogoń A; Bretner M; Boguszewska-Chachulska AM Bioorg Med Chem; 2010 Jul; 18(14):5129-36. PubMed ID: 20579888 [TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of new anti-hepatitis C virus agents: heterobicycle-coumarin conjugates. Neyts J; De Clercq E; Singha R; Chang YH; Das AR; Chakraborty SK; Hong SC; Tsay SC; Hsu MH; Hwu JR J Med Chem; 2009 Mar; 52(5):1486-90. PubMed ID: 19193060 [TBL] [Abstract][Full Text] [Related]
13. Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: from anti-pestivirus to anti-hepatitis C virus activity. Puerstinger G; Paeshuyse J; De Clercq E; Neyts J Bioorg Med Chem Lett; 2007 Jan; 17(2):390-3. PubMed ID: 17084081 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of hexahydropyrimidines and diamines as novel hepatitis C virus inhibitors. Hwang JY; Kim HY; Jo S; Park E; Choi J; Kong S; Park DS; Heo JM; Lee JS; Ko Y; Choi I; Cechetto J; Kim J; Lee J; No Z; Windisch MP Eur J Med Chem; 2013; 70():315-25. PubMed ID: 24177358 [TBL] [Abstract][Full Text] [Related]
15. Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors. Kang IJ; Wang LW; Hsu SJ; Lee CC; Lee YC; Wu YS; Yueh A; Wang JC; Hsu TA; Chao YS; Chern JH Bioorg Med Chem Lett; 2009 Nov; 19(21):6063-8. PubMed ID: 19796940 [TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B protein. Tai VW; Garrido D; Price DJ; Maynard A; Pouliot JJ; Xiong Z; Seal JW; Creech KL; Kryn LH; Baughman TM; Peat AJ Bioorg Med Chem Lett; 2014 May; 24(10):2288-94. PubMed ID: 24731273 [TBL] [Abstract][Full Text] [Related]
17. Discovery and structure-activity relationships study of thieno[2,3-b]pyridine analogues as hepatic gluconeogenesis inhibitors. Ma F; Liu J; Zhou T; Lei M; Chen J; Wang X; Zhang Y; Shen X; Hu L Eur J Med Chem; 2018 May; 152():307-317. PubMed ID: 29733999 [TBL] [Abstract][Full Text] [Related]
18. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine. Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482 [TBL] [Abstract][Full Text] [Related]
19. 4'-Substituted pyrimidine nucleosides lacking 5'-hydroxyl function as potential anti-HCV agents. Shakya N; Vedi S; Liang C; Yang F; Agrawal B; Kumar R Bioorg Med Chem Lett; 2014 Mar; 24(5):1407-9. PubMed ID: 24485784 [TBL] [Abstract][Full Text] [Related]
20. Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors. Sheng XC; Pyun HJ; Chaudhary K; Wang J; Doerffler E; Fleury M; McMurtrie D; Chen X; Delaney WE; Kim CU Bioorg Med Chem Lett; 2009 Jul; 19(13):3453-7. PubMed ID: 19477126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]